FindTrial
Sign In

Assessment of the efficacy of Ksheerbala Tail Marsha Nasya in Avabahuka With Special Reference To Frozen Shoulder: Randomized Controlled Trial

Assessment of the efficacy of Ksheerbala Tail Marsha Nasya in Avabahuka : Randomized Controlled Trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085037
Enrollment
74
Registered
2025-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

None listed

Sponsors

PMTS AYURVEDA COLLEGE Shevgaon
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Screened cases of Avabahuka. Patient willing for treatment with written consent.

Exclusion criteria

Exclusion criteria: K/c/o HIV,HCV,HBsAg positive patients. Pregnant and lactating women. Patient with history of trauma or fracture of affected hand. Patient with systemic disease.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Ksheerbala Taila Marsha Nasya In Avabahuka With Special Reference To Frozen ShoulderTimepoint: 7 days treatment with follow up on baseline 0,7th,14th 28th day—

Secondary

MeasureTime frame
To review the literature about Avabahuka in view of Ayurveda. To review the literature about Frozen Shoulder in view of modern medical science. To evaluate efficacy of swalpa Masha Taila Nasya In Avabahuka. To compare the efficacy of Ksheerbala Taila Marsha Nasya and swalpa Masha Taila Nasya In Avabahuka With Special Reference To Frozen Shoulder. To Observe any adverse drug reaction.Timepoint: 7 days treatment with four follow up on 0,7th, 14th and 28th day.—

Countries

India

Contacts

Public ContactDr Sachin Gandhi

PMTs Ayurved College Shevgaon

arihantsai977@gmail.com9423389866

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026